Conditions: Healthy
Keywords: PK and Safety
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 36
Healthy volunteers: yes

Brief summary:
Pharmacokinetics, safety and wearability in two size patches of AG890 over eight weeks will be evaluated.

Detailed description:
To evaluate pharmacokinetic (PK) profile, patch wearability (adhesion and skin irritation), and safety of AG890-6.5 and AG890-12.5 TCDS.

Arms:
arm 1: Evaluate levonorgestrel delivery in AG890-6.5 arm 2: Evaluate levonorgestrel delivery in AG890-12.5

Interventions: intervention 1: levonorgestrel
Intervention descriptions: intervention 1: transdermal contraceptive delivery system

Protocol document: